Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Beximco Pharmaceuticals Limited Sponsored GDR RegS ( (GB:BXP) ).
Beximco Pharmaceuticals Limited has requested an extension from the Bangladesh Securities and Exchange Commission and local stock exchanges to publish its Q3 financial results. The delay is due to the pending appointment of nine independent non-executive directors to the company’s board, a matter currently awaiting resolution in the High Court of Bangladesh. This situation may impact the company’s governance and financial reporting timeline.
More about Beximco Pharmaceuticals Limited Sponsored GDR RegS
Beximco Pharmaceuticals Limited is a leading manufacturer and exporter of generic pharmaceutical products and active pharmaceutical ingredients based in Bangladesh. Established in 1976, the company offers a broad portfolio of generics, including tablets, capsules, liquids, and more, and engages in contract manufacturing for global pharmaceutical companies. Its state-of-the-art facilities are certified by regulatory authorities worldwide, and it operates in over 50 countries with a workforce of more than 6,000 employees.
YTD Price Performance: 2.56%
Average Trading Volume: 37,993
Technical Sentiment Signal: Hold
For an in-depth examination of BXP stock, go to TipRanks’ Stock Analysis page.